Beneficial effects of atorvastatin on renal function in chronic kidney disease patients after primary percutaneous coronary intervention who were on rosuvastatin

被引：0
|
作者：
Sato, T. [1 ]
Kameyama, T. [2 ]
Inoue, H. [2 ]
机构：
[1] Itoigawa Gen Hosp, Itoigawa, Japan
[2] Toyama Univ, Toyama 930, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1029
页数：1
相关论文
共 50 条
  • [31] Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
    Genjiro Kimura
    Masato Kasahara
    Kenji Ueshima
    Sachiko Tanaka
    Shinji Yasuno
    Akira Fujimoto
    Toshiya Sato
    Miyuki Imamoto
    Shinji Kosugi
    Kazuwa Nakao
    Clinical and Experimental Nephrology, 2017, 21 : 417 - 424
  • [32] Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
    Kimura, Genjiro
    Kasahara, Masato
    Ueshima, Kenji
    Tanaka, Sachiko
    Yasuno, Shinji
    Fujimoto, Akira
    Sato, Toshiya
    Imamoto, Miyuki
    Kosugi, Shinji
    Nakao, Kazuwa
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 417 - 424
  • [33] Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
    Firouzi, Ata
    Moussavi, Ali Kazem
    Mohebbi, Ahmad
    Aleinzadeh-Ansari, Mohammad Javad
    Kiani, Reza
    Sanati, Hamid Reza
    Mohebbi, Bahram
    Shakerian, Farshad
    Zahedmehr, Ali
    Ansari-Ramandi, Mohammad Mostafa
    Heris, Saeed Oni
    Ghaleshi, Bahar
    Ghorbani, Fatemeh
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2018, 10 (03) : 149 - 152
  • [34] Determinants of Mortality in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
    Papachristidis, Alexandros
    Lim, Wei Yao
    Voukalis, Christos
    Ayis, Salma
    Laing, Christopher
    Rakhit, Roby D.
    CARDIORENAL MEDICINE, 2016, 6 (03) : 169 - 179
  • [35] Contrast-induced nephropathy after a second percutaneous coronary intervention in patients with chronic kidney disease
    覃雪清
    谭宁
    甘富东
    周颖玲
    陈纪言
    杨大浩
    South China Journal of Cardiology, 2011, 12 (04) : 227 - 240
  • [36] Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease
    Guedeney, Paul
    Sorrentino, Sabato
    Vogel, Birgit
    Baber, Usman
    Claessen, Bimmer E.
    Mehran, Roxana
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2018, 16 (11) : 825 - 835
  • [37] Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention
    Zhu, Pei
    Tang, Xiao-Fang
    Xu, Jing-Jing
    Song, Ying
    Liu, Ru
    Zhang, Yin
    Gao, Lijian
    Gao, Zhan
    Chen, Jue
    Yang, Yue-Jin
    Gao, Run-Lin
    Xu, Bo
    Yuan, Jin-Qing
    PLATELETS, 2019, 30 (07) : 901 - 907
  • [38] The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction
    Celik, T
    Kursaklioglu, H
    Iyisoy, A
    Kose, S
    Kilic, S
    Amasyali, B
    Kardesoglu, E
    Isik, E
    CORONARY ARTERY DISEASE, 2005, 16 (05) : 321 - 326
  • [39] Outcomes after percutaneous coronary interventions in patients with chronic kidney disease
    Tan Huay Cheem
    Journal of Geriatric Cardiology, 2005, (03) : 183 - 187
  • [40] EFFECTS OF CHRONIC KIDNEY DISEASE STAGING ON IN-HOSPITAL OUTCOMES OF PATIENTS UNDERWENT PERCUTANEOUS CORONARY INTERVENTION
    Limpijankit, Thosaphol
    Boonbaichaiyapruck, Sarana
    Pienvichit, Pavit
    Chandavimol, Mann
    Meemook, Krissada
    Srimahachota, Suphot
    Siriyotha, Sukanya
    Thakkinstian, Ammarin
    Sansanayudh, Nakarin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 82 - 82
12345